They have to fix that if they want to get onto a major stock exchange. I'm assuming that is the ultimate plan. With only 34M shares issued they are clearly not interested in diluting the stock to make a quick profit.
If you look at their management and MD's putting their reputation on the line, it's easy to see IMMD does not belong in OTC land, IMO.
I hope I am right.
GLTA
$$$$ IMMD $$$$
... and they are expecting another patent to be issued in 2017, witch many people forget, or don't even know about. If Shapiro sales won't disappointing and patent gets issued, $1+ easy, by the end of the year, IMO.
IMMD LONG!
News 
Market Data 
Discover 
